Format

Send to

Choose Destination
Lancet. 1991 Jan 19;337(8734):149-52.

Randomised clinical trials with clinician-preferred treatment.

Author information

1
Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892.

Abstract

The standard design for randomised clinical trials may be inappropriate when the clinician believes that one of the treatments being tested is superior for the patient, or when the clinician has a preference for one of the treatments. For such instances the suggestion is that the patient is randomly allocated to treatment only when there is clinical disagreement about treatment of choice for that patient, and then the patient is assigned to a clinician who had thought that the regimen allocated is the one most appropriate for that patient.

PMID:
1670796
DOI:
10.1016/0140-6736(91)90809-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center